Showing results (251-260 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 7, 2004
Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041)Gretchen Kimmick, Mark J Ratain, Don Berry, et al.
Investigational New Drugs|January 1, 1987
Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitroR Saydjari, C M Townsend, S C Barranco, et al.
Investigational New Drugs|July 2, 2019
Targeting ROS overgeneration by N-benzyl-2-nitro-1-imidazole-acetamide as a potential therapeutic reposition approach for cancer therapyRodrigo C Zeferino, Nádia S R S Mota, Valdelúcia M A S Grinevicius, et al.
Investigational New Drugs|July 3, 2019
Xanthan gum-based hydrogel containing nanocapsules for cutaneous diphenyl diselenide delivery in melanoma therapyLuana Mota Ferreira, Marcel Henrique Marcondes Sari, Juliana Hofstatter Azambuja, et al.
Investigational New Drugs|July 3, 2019
Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastomaLucy Swift, Chunfen Zhang, Olga Kovalchuk, et al.
Investigational New Drugs|June 25, 2019
A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid componentInkeun Park, Hyo Jin Lee, Woo Kyoon Bae, et al.
Investigational New Drugs|June 29, 2019
Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot studyVladimir J Lozanovski, Georgios Polychronidis, Wolfgang Gross, et al.
Investigational New Drugs|July 4, 2019
T cell cytotoxicity toward hematologic malignancy via B7-H3 targetingXin Sun, Yang Yu, Li Ma, et al.
Investigational New Drugs|July 10, 2019
Autophagy inhibition potentiates ruxolitinib-induced apoptosis in JAK2V617F cellsJoão Agostinho Machado-Neto, Juan Luiz Coelho-Silva, Fábio Pires de Souza Santos, et al.
Investigational New Drugs|July 11, 2019
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility studyKenichi Inoue, Shigenori E Nagai, Tsuyoshi Saito, et al.
Pageof 372